The activity of acyl-CoA: cholesterol acyltransferase (ACAT; EC 2.3.1.26) was measured in fibroblast homogenates from Niemann-Pick Type C (NPC) and Type D (NPD) patients to determine whether these cells exhibit similar defects in the regulation of cholesterol esterification. ACAT activity in normal cells cultured in the absence of serum lipoproteins responded rapidly (within 6 h) to the addition of serum and reached peak levels at 12-24 h, whereas little stimulation of activity in NPC cells was observed. In contrast, ACAT activity in NPD fibroblasts (cell lines from four different patients) began to increase between 6 and 12 h after serum addition, reaching levels up to 50 % of normal values at 24 h. ACAT activity in NPC and NPD cell extracts could not be stimulated by preincubation with normal cell homogenates, nor was complementation between NPC and NPD homogenates observed. Addition of 25-hydroxycholesterol to fibroblasts cultured in delipidated serum increased ACAT activity for all three cell types, although stimulation in NPD cells was less than that observed in NPC cells. ACAT activity of deoxycholatesolubilized homogenates reconstituted into phosphatidylcholine vesicles was independent of the presence of serum lipoproteins during culture and dependent on cholesterol present in the vesicles for all cell types. However, ACAT activities of mutant fibroblasts in vesicles plus cholesterol were significantly (about 40 %) lower than control levels. These results suggest that the metabolic lesions in NPC and NPD cells are biochemically distinct and that both may involve factors in addition to the availability of cholesterol substrate for the ACAT enzyme.
INTRODUCTION
The human fibroblast has been an important model for the study of intracellular cholesterol metabolism and regulation in peripheral cells [1, 2] . The normal response of fibroblasts cultured in lipoprotein-deficient (LPD) serum to the addition of low-density lipoprotein (LDL) to the medium is three-fold: (1) a decrease in the synthesis of LDL receptors and their expression on the cell surface, (2) regulation of 3-hydroxy-3-methylglutaryl-CoA reductase activity resulting in decreased cholesterol synthesis de novo and (3) an increase in the activity of acylCoA: cholesterol acyltransferase (ACAT; EC 2.3.1.26) leading to the storage of excess cholesterol as cholesteryl esters [1, 3] . Mutations affecting intracellular cholesterol metabolism, such as defective LDL receptor activity in familial hypercholesterolaemia [1] , have been invaluable in the elucidation of these pathways.
The Niemann-Pick group of diseases is characterized by variable accumulation of cholesterol in addition to the sphingomyelin storage considered typical of the condition [4] . In one group of patients, called Type I [4] , the primary defect appears to be a deficiency of the lysosomal hydrolase, sphingomyelinase. In a second group of patients, called Type II, sphingomyelinase activity may be normal. The latter group includes the panethnic Niemann-Pick disease Type C (NPC), and the Acadian Niemann-Pick Type D (NPD) [4] . Recently, Pentchev and his coworkers [5, 6] demonstrated an abnormality in intracellular cholesterol esterification in fibroblasts from patients with NPC. Subsequent studies have suggested the defect to be more general in intracellular cholesterol metabolism since all three regulatory pathways are affected in NPC cells [7, 8] and mutant cells do not exhibit abnormal responses to non-LDL regulators such as 25-hydroxycholesterol and mevalonate [8] . Moreover, NPC cells show a delayed expression of normal responses following addition of LDL, indicating a partial block in the intracellular delivery of cholesterol to regulatory sites [7, 8] . This conclusion is supported by the abnormal storage of LDL-derived cholesterol in lysosomes from NPC cells [9] . A similar defect in NPD has been suggested, based on studies of patients whose maternal ancestry was Acadian [10] .
The present investigation was initiated to establish a system for the study of [8] . Human serum, obtained fresh from local donors, was delipidated by preparative ultracentrifugation [11] .
Cell culture
Normal and NPD fibroblasts were obtained from skin biopsy of four healthy individuals and from four local patients diagnosed with Niemann-Pick disease Type D, respectively. The paternal and maternal ancestry of all Type D subjects can be traced to the Acadian population of southwestern Nova Scotia [4] . Two NPC fibroblast cell lines (GMO110 and GM3123) were purchased from the Human Genetic Mutant Cell Repository (Camden, NJ, U.S.A.); these particular cell lines have previously been shown to be defective in cholesterol esterification [5] . Another NPC cell line was a gift from Dr. J. Callahan, Hospital for Sick Children, Toronto, Canada. Fibroblasts were maintained at 37°C in an atmosphere of 500 CO2 and were used between the 7th and 13th passage.
In most experiments, cells were seeded in 4ml of minimal essential medium (MEM; Gibco, Grand Island, NY, U.S.A.) containing 100 (v/v) LPD-FBS in 60 mm dishes at a density of (1.6-2) x 105 cells per dish. Following a culture period of 3 days, this medium was replaced with 2 ml of MEM containing 100 LPD-FBS or 100 FBS. After further incubation (typically 12 h), fibroblasts were harvested as outlined below and used for preparation of cell homogenates and assay for ACAT within 2 h.
Cell harvest and lysis
All operations were carried out at 0 'C. Fibroblasts were harvested by scraping in phosphate-buffered saline; cells from three identical dishes were pooled to obtain a cell pellet by centrifugation (2000 g, 10 min). Cell pellets were transferred to a manual ground-glass homogenizer and disrupted by 30 strokes in a total volume of 150,l of 10 mM-potassium phosphate (pH 7.4)/i mM-dithiothreitol/1 mM-EDTA. The resulting homogenate was used for duplicate or triplicate enzyme assay after removal of aliquots for protein determination [12] . The measurement of ACAT activity in phospholipid/ cholesterol vesicles was carried out essentially as described by Cadigan et al. [15] . Vesicles containing 10 mg of phosphatidylcholine/ml with or without 1.5 mg of cholesterol/ml were prepared in 50 mM-Tris/HCl/5 mM-EDTA at pH 7.8 (buffer A) by treatment with cholestyramine resin [16] . Cell homogenates prepared as described above were solubilized by addition of 0.25 vol. of 10 Fig. 1 Fig. 3 . Effects of 25-hydroxycholesterol on ACAT activity
It has been reported that the apparent regulatory defect in NPC fibroblasts which results in low ACAT activity is specific for LDL-derived cholesterol, since cholesterol esterification in intact cells can be partially [7] or completely [8] stimulated to normal levels by the polar derivative 25-hydroxycholesterol. As shown in Fig. 4 , the addition of 25-hydroxycholesterol during culture in the presence of LPD-FBS also produced an increase in the resultant ACAT activity of both normal and Niemann-Pick fibroblast homogenates. In the case of NPC cells, this stimulation was substantially greater than that produced by FBS. In contrast to the effects of serum on ACAT activity, 25-hydroxycholesterol appeared to produce a greater stimulation of ACAT in NPC than in NPD cells (Fig. 4) . This was also observed with cells cultured for different time intervals in the presence of serum LDL (Table 2) . Although the nature of the data shown in Fig. 4 and Fig. 4 suggest that impaired ACAT activity in Niemann-Pick cells is at least in part due to a proximal effect on cholesterol substrate concentration in the microsome rather than a molecular defect in ACAT itself. To address this question directly, we have taken advantage of a recently described assay system in which detergent-solubilized homogenates are reconstituted into phosphatidylcholine vesicles containing a specific amount of cholesterol [15] . Under these conditions, ACAT activity is completely dependent upon added vesicle cholesterol rather than on endogenous sterol levels [15, 17] . Indeed, when normal and mutant cells grown in FBS were reconstituted into vesicles without cholesterol, ACAT activity was very low (< 5 pmol/min per mg, results not shown).
In a representative experiment shown in Table 3 , the ACAT activities of normal, NPC 
DISCUSSION
Despite the importance of ACAT in the regulation of intracellular cholesterol metabolism [3] , this enzyme has never been purified to homogeneity nor is its amino acid sequence known. ACAT activity, situated in the RNArich region of the rough endoplasmic reticulum [18] , is subject to a complex array of regulatory influences, including the local substrate concentration of cholesterol [17, 19] , regulatory effects of sterols [20, 21] and protein factors [22] , membrane fluidity [23] , and covalent modification by phosphorylation [24] [25] [26] . These signals [7, 8] . A defect in intracellular processing of LDL-derived cholesterol could affect ACAT activity by reducing cholesterol transport to the enzyme itself (substrate, allosteric and fluidity effects) or by failure to generate the appropriate second messenger(s) involved in regulation of enzyme activity [8] .
The present study in vitro was initiated to address the regulation of cholesterol esterification under conditions in which the environment of the enzyme can be more carefully controlled. The rapid increase and eventual decline of ACAT activity that we have observed for normal fibroblasts after addition of serum containing LDL is consistent with the known effects of LDL on ACAT stimulation and receptor turnover in intact cells [1] [2] [3] . Gavigan & Knight [19] also observed a transient LDL-stimulated increase in ACAT activity of fibroblast microsomal preparations and further demonstrated that this response is due to an increase in local cholesterol substrate concentration. We have adapted a vesicle assay originally developed for Chinese hamster ovary cells [17] and have demonstrated that endogenous cholesterol concentration is an important determinant of ACAT activity in both normal and NP fibroblasts.
On the other hand, our data provide evidence that impaired ACAT activity in NPC and NPD cells is not completely corrected by increasing local substrate availability. This further limitation on ACAT activity in mutant cells could involve incomplete activation of the enzyme by a covalent mechanism (i.e. phosphorylation), or by non-covalent factors which survive detergent solubilization and reconstitution, or it could reflect depressed levels of ACAT protein in these cells. The previous finding that normal levels of ACAT activity can be observed in NPC homogenates prepared under certain lysis conditions [7, 9] is particularly interesting in this regard. In addition to using a different lysis protocol from that employed here, these workers have used an assay in which [3H]oleic acid, ATP and CoA are incubated with homogenates for a period of 2 h at 37 'C. Since the specific activities obtained were much lower (< 5 pmol/min per mg of protein [9] ) than those we have observed using ["4C]oleoyl-CoA in a 10 min assay, it is possible that a different rate-determining step was being measured in their assay. In any case, we suggest that careful attention to the differences in these protocols might be exploited in further localization of the molecular defect in Niemann-Pick cells.
The present experiments clearly indicate that the responses of ACAT activity to culture manipulations are different in NPC and NPD fibroblasts. In particular, NPD cells exhibited a stronger, more rapid response to LDL than did NPC cells, while the latter showed greater stimulation by a non-lipoprotein effector, 25- hydroxycholesterol. In the only previous report of cholesterol esterification in NPD cells, Butler et al. [10] found no significant difference in cholesterol esterification rates or in ACAT activity in vitro between NPC and NPD fibroblasts do not accumulate excess total cholesterol. Further studies will be necessary to determine esterol. Further studies will be necessary to determine whether biochemical and clinical differences between NPC and NPD are due to mutations in different genes or to a single mutation differing in severity and thus in effects on the complex regulatory network of intracellular cholesterol metabolism.
